Prokidney (PROK) Directors and Executive Officers

Officers & Directors

Pablo Legorreta
Chairman

Alan M. Lotvin, M.D.
Director

John M. Maraganore, Ph.D.
Director

Bruce Culleton
Chief Executive Officer

Bruce Culleton
Chief Executive Officer and Director

Brian J.G. Pereira, M.D.
Director

William F. Doyle
Director

James Coulston
Chief Financial Officer

Uma Sinha, Ph.D.
Director

Jennifer Fox
Director

Jose Ignacio Jimenez Santos
Director ,

Prokidney Corp currently has 231 employees.

News about Prokidney Corp Key Personnel

ProKidney Corp Raises $140 Million in Public and Direct Offering, Fueling Breakthroughs in Chronic Kidney Disease Therapeutics

ProKidney Corp Announces Successful Closing of $140 Million Public Offering and Registered Direct Offering
ProKidney Corp, a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease, has recently completed a significant financial milestone. The company has successfully closed a public offering and concurrent registered direct offering, raising a total of $140 million.
In the public offering, ProKidney sold 46,886,452 Class A ordinary shares to the public at a price of $2.42 per share. This includes an additional 4,142,232 Class A ordinary shares that were sold as a result of the underwriters exercising their option to purchase additional shares. The total value of ...

ProKidney's Strategic Leadership Appointments to Drive Clinical and Technical Excellence Amid Financial Challenges

ProKidney Strengthens Clinical and Technical Operations with Key Leadership Appointments
ProKidney, a prominent player in the healthcare sector, has recently announced significant leadership appointments aimed at bolstering its clinical and technical operations. Dr. Ulrich Ernst has joined the company as the Executive Vice President of Technical Operations, bringing with him extensive expertise in the field of process development and manufacturing of cell therapies. These strategic moves come at a time when ProKidney is facing challenges, with a decline in stock values and a cumulative net loss over the past year.
Dr. Ulrich Ernst s appointment as the Executive Vice President of Technical Operations ...